Granted IMC-G.A.P. Equivalency Certification by Control Union (“CU”)Milestone to export to Israel and EU-GMP facilities in Europe and ...
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
The Global Vial Adaptors for Reconstitution Drug market is poised for substantial growth, reflecting strong financial projections and industry expansion. In 2023, the market was valued at USD 2,186.69 ...
The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial projections and industry expansion.
‘It assumes humans are always 10 times more sensitive than the test animals and that there is an additional 10 times variation in sensitivity ... ‘almost every regulatory agency – including the ...
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have ...
AMSTERDAM – The European Medicines Agency (EMA) said on Jan 27 that it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...
IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...
PARIS — European leaders gathered in Paris Monday ... he said on the sidelines of an election campaign event, German news agency dpa reported. "A ceasefire must not lead to Russian rearmament ...
Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...
More leaders attended this time, including from non-European-Union (EU) countries such as Canada and Norway. While the full details of those talks were not made public, in the last few days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results